These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 9393971

  • 1. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF, Leder P.
    Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
    [Abstract] [Full Text] [Related]

  • 2. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI, Leder P.
    Oncogene; 1996 Dec 19; 13(12):2507-15. PubMed ID: 9000125
    [Abstract] [Full Text] [Related]

  • 3. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA, Kittrell FS, Medina D, Butel JS.
    Oncogene; 2001 Nov 15; 20(52):7645-57. PubMed ID: 11753642
    [Abstract] [Full Text] [Related]

  • 4. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 5. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice.
    Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S.
    Cancer Res; 1992 Aug 15; 52(16):4413-9. PubMed ID: 1386556
    [Abstract] [Full Text] [Related]

  • 6. TGF beta regulation of cell proliferation.
    Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF, Serra R.
    Princess Takamatsu Symp; 1994 Aug 15; 24():250-63. PubMed ID: 8983080
    [Abstract] [Full Text] [Related]

  • 7. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia.
    Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA.
    Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935
    [Abstract] [Full Text] [Related]

  • 8. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 26; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

  • 9. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH, Jang SH, Kang BC, Kim HJ, Oh SH, Kong G.
    J Cell Physiol; 2011 May 26; 226(5):1340-52. PubMed ID: 20945346
    [Abstract] [Full Text] [Related]

  • 10. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH.
    Cancer Res; 1996 Apr 15; 56(8):1775-85. PubMed ID: 8620493
    [Abstract] [Full Text] [Related]

  • 11. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.
    Elson A.
    Oncogene; 1999 Dec 09; 18(52):7535-42. PubMed ID: 10602512
    [Abstract] [Full Text] [Related]

  • 12. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
    Chooi KF, Carter DA, Biswas S, Lightman SL, Ho MY, Murphy D.
    Cancer Res; 1994 Dec 15; 54(24):6434-40. PubMed ID: 7987839
    [Abstract] [Full Text] [Related]

  • 13. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.
    Oncogene; 1998 May 28; 16(21):2755-66. PubMed ID: 9652742
    [Abstract] [Full Text] [Related]

  • 14. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA, Troyer KL, Lee DC.
    Oncogene; 2000 Jun 29; 19(28):3193-9. PubMed ID: 10918574
    [Abstract] [Full Text] [Related]

  • 15. Control of the three-dimensional growth pattern of mammary epithelium: role of genes of the Wnt and erbB families studied using reconstituted epithelium.
    Edwards PA.
    Biochem Soc Symp; 1998 Jun 29; 63():21-34. PubMed ID: 9513708
    [Abstract] [Full Text] [Related]

  • 16. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P.
    Proc Natl Acad Sci U S A; 1995 Mar 14; 92(6):2268-72. PubMed ID: 7892260
    [Abstract] [Full Text] [Related]

  • 17. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH.
    Virology; 1995 Oct 01; 212(2):490-9. PubMed ID: 7571419
    [Abstract] [Full Text] [Related]

  • 18. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
    Morini M, Astigiano S, Mora M, Ricotta C, Ferrari N, Mantero S, Levi G, Rossini M, Barbieri O.
    Oncogene; 2000 Dec 07; 19(52):6007-14. PubMed ID: 11146552
    [Abstract] [Full Text] [Related]

  • 19. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
    Krane IM, Leder P.
    Oncogene; 1996 Apr 18; 12(8):1781-8. PubMed ID: 8622899
    [Abstract] [Full Text] [Related]

  • 20. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX, Papkoff J, Sarkar NH.
    Virology; 1999 Mar 01; 255(1):138-49. PubMed ID: 10049829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.